272 related articles for article (PubMed ID: 32042099)
1. Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis.
Mancarella S; Serino G; Dituri F; Cigliano A; Ribback S; Wang J; Chen X; Calvisi DF; Giannelli G
Cell Death Differ; 2020 Aug; 27(8):2330-2343. PubMed ID: 32042099
[TBL] [Abstract][Full Text] [Related]
2. Crenigacestat blocking notch pathway reduces liver fibrosis in the surrounding ecosystem of intrahepatic CCA viaTGF-β inhibition.
Mancarella S; Gigante I; Serino G; Pizzuto E; Dituri F; Valentini MF; Wang J; Chen X; Armentano R; Calvisi DF; Giannelli G
J Exp Clin Cancer Res; 2022 Nov; 41(1):331. PubMed ID: 36443822
[TBL] [Abstract][Full Text] [Related]
3. CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype.
Mancarella S; Serino G; Gigante I; Cigliano A; Ribback S; Sanese P; Grossi V; Simone C; Armentano R; Evert M; Calvisi DF; Giannelli G
J Exp Clin Cancer Res; 2022 Feb; 41(1):65. PubMed ID: 35172861
[TBL] [Abstract][Full Text] [Related]
4. The Tumor Microenvironment Drives Intrahepatic Cholangiocarcinoma Progression.
Mancarella S; Serino G; Coletta S; Armentano R; Dituri F; Ardito F; Ruzzenente A; Fabregat I; Giannelli G
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457006
[TBL] [Abstract][Full Text] [Related]
5. Amarogentin Inhibits Liver Cancer Cell Angiogenesis after Insufficient Radiofrequency Ablation via Affecting Stemness and the p53-Dependent VEGFA/Dll4/Notch1 Pathway.
Zhang Y; Zhang Y; Wang J; Gu H
Biomed Res Int; 2020; 2020():5391058. PubMed ID: 33145353
[TBL] [Abstract][Full Text] [Related]
6. MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs.
Yang R; Wang D; Han S; Gu Y; Li Z; Deng L; Yin A; Gao Y; Li X; Yu Y; Wang X
Int J Biol Sci; 2022; 18(1):43-64. PubMed ID: 34975317
[No Abstract] [Full Text] [Related]
7. The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma.
Di Matteo S; Nevi L; Costantini D; Overi D; Carpino G; Safarikia S; Giulitti F; Napoletano C; Manzi E; De Rose AM; Melandro F; Bragazzi M; Berloco PB; Giuliante F; Grazi G; Giorgi A; Cardinale V; Adorini L; Gaudio E; Alvaro D
PLoS One; 2019; 14(1):e0210077. PubMed ID: 30677052
[TBL] [Abstract][Full Text] [Related]
8. YAP Accelerates Notch-Driven Cholangiocarcinogenesis via mTORC1 in Mice.
Lu X; Peng B; Chen G; Pes MG; Ribback S; Ament C; Xu H; Pal R; Rodrigues PM; Banales JM; Evert M; Calvisi DF; Chen X; Fan B; Wang J
Am J Pathol; 2021 Sep; 191(9):1651-1667. PubMed ID: 34129844
[TBL] [Abstract][Full Text] [Related]
9. MUC13 promotes intrahepatic cholangiocarcinoma progression via EGFR/PI3K/AKT pathways.
Tiemin P; Fanzheng M; Peng X; Jihua H; Ruipeng S; Yaliang L; Yan W; Junlin X; Qingfu L; Zhefeng H; Jian L; Zihao G; Guoxing L; Boshi S; Ming Z; Qinghui M; Desen L; Lianxin L
J Hepatol; 2020 Apr; 72(4):761-773. PubMed ID: 31837357
[TBL] [Abstract][Full Text] [Related]
10. The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.
Cigliano A; Zhang S; Ribback S; Steinmann S; Sini M; Ament CE; Utpatel K; Song X; Wang J; Pilo MG; Berger F; Wang H; Tao J; Li X; Pes GM; Mancarella S; Giannelli G; Dombrowski F; Evert M; Calvisi DF; Chen X; Evert K
J Exp Clin Cancer Res; 2022 Jun; 41(1):192. PubMed ID: 35655220
[TBL] [Abstract][Full Text] [Related]
11. Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cells.
López-Guerra M; Xargay-Torrent S; Fuentes P; Roldán J; González-Farré B; Rosich L; Silkenstedt E; García-León MJ; Lee-Vergés E; Giménez N; Giró A; Aymerich M; Villamor N; Delgado J; López-Guillermo A; Puente XS; Campo E; Toribio ML; Colomer D
Oncogene; 2020 Feb; 39(6):1185-1197. PubMed ID: 31616059
[TBL] [Abstract][Full Text] [Related]
12. Axitinib (AG-013736), an oral specific VEGFR TKI, shows potential therapeutic utility against cholangiocarcinoma.
Takahashi H; Ojima H; Shimizu H; Furuse J; Furukawa H; Shibata T
Jpn J Clin Oncol; 2014 Jun; 44(6):570-8. PubMed ID: 24755544
[TBL] [Abstract][Full Text] [Related]
13. Loss of Numb promotes hepatic progenitor expansion and intrahepatic cholangiocarcinoma by enhancing Notch signaling.
Shu Y; Xu Q; Xu Y; Tao Q; Shao M; Cao X; Chen Y; Wu Z; Chen M; Zhou Y; Zhou P; Shi Y; Bu H
Cell Death Dis; 2021 Oct; 12(11):966. PubMed ID: 34667161
[TBL] [Abstract][Full Text] [Related]
14. A novel peptide inhibitor of Dll4-Notch1 signalling and its pro-angiogenic functions.
Zhu G; Lin Y; Ge T; Singh S; Liu H; Fan L; Wang S; Rhen J; Jiang D; Lyu Y; Yin Y; Li X; Benoit DSW; Li W; Xu Y; Pang J
Br J Pharmacol; 2022 Apr; 179(8):1716-1731. PubMed ID: 34796471
[TBL] [Abstract][Full Text] [Related]
15. Notch1 Drives the Formation and Proliferation of Intrahepatic Cholangiocarcinoma.
Guo J; Fu W; Xiang M; Zhang Y; Zhou K; Xu CR; Li L; Kuang D; Ye F
Curr Med Sci; 2019 Dec; 39(6):929-937. PubMed ID: 31845224
[TBL] [Abstract][Full Text] [Related]
16. Unveiling the role of HP1α-HDAC1-STAT1 axis as a therapeutic target for HP1α-positive intrahepatic cholangiocarcinoma.
Xiong F; Wang D; Xiong W; Wang X; Huang WH; Wu GH; Liu WZ; Wang Q; Chen JS; Kuai YY; Wang B; Chen YJ
J Exp Clin Cancer Res; 2024 May; 43(1):152. PubMed ID: 38812060
[TBL] [Abstract][Full Text] [Related]
17. Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy.
Silkenstedt E; Arenas F; Colom-Sanmartí B; Xargay-Torrent S; Higashi M; Giró A; Rodriguez V; Fuentes P; Aulitzky WE; van der Kuip H; Beà S; Toribio ML; Campo E; López-Guerra M; Colomer D
J Exp Clin Cancer Res; 2019 Nov; 38(1):446. PubMed ID: 31676012
[TBL] [Abstract][Full Text] [Related]
18. Plasmalemma vesicle-associated protein promotes angiogenesis in cholangiocarcinoma via the DKK1/CKAP4/PI3K signaling pathway.
Wang Y; Yu H; Xie X; Deng T; Ye L; Wu L; Ding X; Yang Z; Zhu Q; Li J; Zheng Y; Yu Z; Chen G
Oncogene; 2021 Jun; 40(25):4324-4337. PubMed ID: 34079085
[TBL] [Abstract][Full Text] [Related]
19. Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling.
Frampton G; Coufal M; Li H; Ramirez J; DeMorrow S
Exp Cell Res; 2010 May; 316(9):1465-78. PubMed ID: 20347808
[TBL] [Abstract][Full Text] [Related]
20. No evidence for a functional role of bi-directional Notch signaling during angiogenesis.
Liebler SS; Feldner A; Adam MG; Korff T; Augustin HG; Fischer A
PLoS One; 2012; 7(12):e53074. PubMed ID: 23300864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
